Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Apr 22.

Published in final edited form as: Alzheimers Dement. 2018 Nov 9;15(3):487–496. doi: 10.1016/j.jalz.2018.09.010

Table 2 -.

Patient characteristics

	Discovery cohort (HABS + UCL)				Validation cohort (UCSD)
	NC (HABS, n=10)	NC (UCL, n=9)	AD-MCI (n=21)	AD (n=25)	NC (n=41)	AD-MCI (n=22)	AD (n=23)
	N (%) or mean ± SD	N (%) or mean ± SD	N (%) or mean ± SD	N (%) or mean ± SD	N (%) or mean ± SD	N (%) or mean ± SD	N (%) or mean ± SD
Gender (female)	7 (70.0)	7 (77.8)	16 (76.2)	13 (52.0)	27 (56.3)	10 (45.5)	12 (52.2)
Age (years)	69.8 ± 9.8	59.8 ± 6.5	65.3 ± 6.7	61.0 ± 6.3	71.8 ± 6.0	73.2 ± 8.1	72.4 ± 8.3
MMSE	n. a.	29.4 ± 0.5	26.1 ± 1.2	20.0 ± 2.9	29.3 ± 0.8	26.9 ± 1.4	19.8 ± 2.4
CSF Aβ (pg/ml)	972.7 ± 199.7	950.4 ± 212.0	405.2 ± 83.7	384.0 ± 130.3	947.0 ± 193.3	497.3 ± 72.0	433.4 ± 84.7
CSF Tau (pg/ml)	236.1 ± 72.2	282.1 ± 78.5	861.3 ± 373.3	921.2 ± 480.4	245.6 ± 104.4	687.3 ± 214.7	641.8 ± 222.3
CSF Tau/Aβ ratio	0.2 ± 0.1	0.3 ± 0.1	2.4 ± 1.4	2.5 ± 1.0	0.3 ± 0.1	1.4 ± 0.4	1.5 ± 0.4